Administration of bisphosphonate for hypercalcemia associated with oral cancer

BACKGROUND: The efficacy of treating hypercalcemia with bisphosphonate (BP) in patients with advanced oral cancer has not been fully investigated. This retrospective study evaluated the clinical course of hypercalcemic patients with and without BP treatment. METHODS: Sixteen hypercalcemic patients,...

Descripción completa

Detalles Bibliográficos
Autores principales: Onizawa, Kojiro, Yoshida, Hiroshi
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1459855/
https://www.ncbi.nlm.nih.gov/pubmed/16603094
http://dx.doi.org/10.1186/1746-160X-2-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1459855/
https://www.ncbi.nlm.nih.gov/pubmed/16603094
http://dx.doi.org/10.1186/1746-160X-2-9

Ejemplares similares